Literature DB >> 16284237

Angiotensin II hypertension is attenuated in interleukin-6 knockout mice.

Dexter L Lee1, Lashon C Sturgis, Hicham Labazi, James B Osborne, Cassandra Fleming, Jennifer S Pollock, Marlina Manhiani, John D Imig, Michael W Brands.   

Abstract

Plasma levels of IL-6 correlate with high blood pressure under many circumstances, and ANG II has been shown to stimulate IL-6 production from various cell types. This study tested the role of IL-6 in mediating the hypertension caused by high-dose ANG II and a high-salt diet. Male C57BL6 and IL-6 knockout (IL-6 KO) mice were implanted with biotelemetry devices and placed in metabolic cages to measure mean arterial pressure (MAP), heart rate (HR), sodium balance, and urinary albumin excretion. Baseline MAP during the control period averaged 114 +/- 1 and 109 +/- 1 mmHg for wild-type (WT) and IL-6 KO mice, respectively, and did not change significantly when the mice were placed on a high-salt diet (HS; 4% NaCl). ANG II (90 ng/min sc) caused a rapid increase in MAP in both groups, to 141 +/- 9 and 141 +/- 4 in WT and KO mice, respectively, on day 2. MAP plateaued at this level in KO mice (134 +/- 2 mmHg on day 14 of ANG II) but began to increase further in WT mice by day 4, reaching an average of 160 +/- 4 mmHg from days 10 to 14 of ANG II. Urinary albumin excretion on day 4 of ANG II was not different between groups (9.18 +/- 4.34 and 8.53 +/- 2.85 microg/2 days for WT and KO mice). By day 14, albumin excretion was nearly fourfold greater in WT mice, but MAP dropped rapidly back to control levels in both groups when the ANG II was stopped after 14 days. Thus the approximately 30 mmHg greater ANG II hypertension in the WT mice suggests that IL-6 contributes significantly to ANG II-salt hypertension. In addition, the early separation in MAP, the albumin excretion data, and the rapid, post-ANG II recovery of MAP suggest an IL-6-dependent mechanism that is independent of renal injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284237     DOI: 10.1152/ajpheart.00708.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  117 in total

1.  Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.

Authors:  Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  Does interleukin 6 contribute to renal hemodynamic changes during angiotensin II-dependent hypertension?

Authors:  Michael J Ryan
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

3.  Adipose tissue as regulator of vascular tone.

Authors:  Charlotte Boydens; Nele Maenhaut; Bart Pauwels; Kelly Decaluwé; Johan Van de Voorde
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

4.  Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells.

Authors:  Ke Li; Dehuang Guo; Haidong Zhu; Kathleen S Hering-Smith; L Lee Hamm; Jingping Ouyang; Yanbin Dong
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-26       Impact factor: 3.619

5.  Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage.

Authors:  Weiru Zhang; Wei Wang; Hong Yu; Yujin Zhang; Yingbo Dai; Chen Ning; Lijian Tao; Hong Sun; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  Hypertension       Date:  2011-11-07       Impact factor: 10.190

6.  TNF-α type 2 receptor mediates renal inflammatory response to chronic angiotensin II administration with high salt intake in mice.

Authors:  Purnima Singh; Laleh Bahrami; Alexander Castillo; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

Review 7.  The immune system in hypertension.

Authors:  Daniel W Trott; David G Harrison
Journal:  Adv Physiol Educ       Date:  2014-03       Impact factor: 2.288

8.  Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension.

Authors:  Romer A Gonzalez-Villalobos; Ryousuke Satou; Dale M Seth; Laura C Semprun-Prieto; Akemi Katsurada; Hiroyuki Kobori; L Gabriel Navar
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

Review 9.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 10.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.